The multicomponent mRNA-1083 vaccine elicited noninferior immune responses in adult patients when compared with coadministered influenza and COVID-19 vaccines.

New analysis warns that suboptimal clinical trial designs and overreliance on surrogate markers may allow less effective flu ...